Abstract
Treatment of bone marrow progenitor cells (BMPC) with zidovudine (AZT) at various concentrations (0.5 to 20 muM) in vitro for 24 hr caused a concentration-dependent decrease in erythropoietin (Epo) receptor expression. The decrease in Epo receptors correlated with a decline in mRNA levels of the receptor. These results suggest that AZT-induced down-regulation of Epo receptor expression followed by loss of Epo-receptor mediated signal transduction is a significant contributory factor to AZT-induced erythroid toxicity.
Original language | English (US) |
---|---|
Pages (from-to) | 1009-1012 |
Number of pages | 4 |
Journal | Biochemical Pharmacology |
Volume | 44 |
Issue number | 6 |
DOIs | |
State | Published - Sep 25 1992 |
ASJC Scopus subject areas
- Biochemistry
- Pharmacology